Work Medical Technology Group Ltd · NASDAQ:WOK

Work Medical Technology — IPO Roadshow (August 2024)

24 slides from Work Medical Technology's IPO roadshow presentation, Aug 9, 2024

  1. Slide 1: Investor Presentation August 2024

    Issuer Free Writing Prospectus dated August 9, 2024 Filed Pursuant to Rule 433 of the Securities Act of 1933, as amended Relating to Preliminary Prospectus dated August 2, 2024 Registration Statement No. 333 - 271474 WORK Medical Technology Group LTD Investor Presentation August 2024

  2. Slide 2: Free Writing Prospectus Statement

    Free Writing Prospectus Statement This free writing prospectus (the “presentation”) relates to the proposed public offering of ordinary shares, par value $ 0 . 0005 per share (“Ordinary Shares”) of WORK Medical Technology Group LTD (“the Company,” “we, ” “us, ” or “our . ”) and should be read togeth

  3. Slide 3: Forward-Looking Statement

    Forward - Looking Statement This presentation contains forward - looking statements, including those listed under “Risk Factors” in the Registration Statement, which may cause our actual results, performance or achievements to be materially different from those expressed or implied therein . You can

  4. Slide 4: Preliminary Offering Summary

    Preliminary Offering Summary WORK Medical Technology Group LTD Issuer Ordinary Shares Securities Initial Public Offering Offering Type Nasdaq Capital Market: WOK Proposed Listing/Symbol 2,000,000 Ordinary Shares, plus up to an additional 300,000 Ordinary Shares, if the underwriter exercises its over

  5. Slide 5: Corporate Structure Outside the PRC

    Corporate Structure 5 Outside the PRC Work Medical Technology Group Limited “Work BVI” British Virgin Islands, 2022 WORK Medical Technology Group LTD “Work Cayman” Cayman,2022 Pre - IPO%/Post - IPO% LWY GROUP LTD British Virgin Islands, 2022 (1) Other Minority Shareholders (2) SANYOU NO.1 GROUP LTD

  6. Slide 6: Company Overview

    Company Overview We are a supplier of medical devices in China. We develop and manufacture Class I and II medical devices and sell Class I and II disposable medical devices through operating subsidiaries in China. Our mission is to become a world - leading manufacturer of medical devices, and we are

  7. Slide 7: Company Overview

    Company Overview Shanghai Saitumofei Medical Treatment Technology Co., Ltd. focuses on the research and development of Class II and III medical devices, and biological and medical technology Research and Development Core Production Base and Domestic and Overseas Sales Chemical Products Sales Medical

  8. Slide 8: Products

    Products Visualized Prostatic Dilatation Catheter • Hangzhou Shanyou received the Medical Device Registration Certificate on October 11, 2023, which enables Hangzhou Shanyou to manufacture the product. Class I Class II Artery Compression Tourniquets Intubating Stylets Guedel Airways Endotracheal Tub

  9. Slide 9: Customers

    Customers Direct End - user Customer • 42 direct end - user customers from hospitals, pharmacies, medical institutions • Gradually shifted their focus to offer long - term and stable revenue contributions Our 913 Customers Domestic Distributor Customer • 849 domestic distributor customers • Cover 34

  10. Slide 10: Quality Control Process Flow Diagrams

    Quality Control Process Flow Diagrams The Quality Control Management System Earned Quality - related Manufacturing Designations Our quality control management system comprehensively covers all manufacturing processes: • Raw Materials Inspection • Production Check • Product Examination • Specifying t

  11. Slide 11: Investment Highlights

    Investment Highlights Deep Understanding of the Industry Wide Distribution Network 11 See offering documents for risks and further disclosures. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of loss. Strong R&D Capabilit

  12. Slide 12: Industry Overview: Growth Rate of Medical Device Market

    Industry Overview Growth Rate of Medical Device Market Size of China and the World 2012 - 2025 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% 2012 2018 2024E 2025 2013 2014 2015 2016 2017 Growth Rate of Global Medical Devices Market Size 2019 2020 2021 2022 2023E Growth Rate of Medical Device

  13. Slide 13: Industry Overview: Largest Medical Device Markets in 2030

    Industry Overview Forecast of Sales Size of Seven Largest Medical Device Markets in 2030 3,050 13 Source: KPMG, Medical Device Industry 2030 Outlook See offering documents for risks and further disclosures. There is no guarantee that any specific outcome will be achieved. Investments may be speculat

  14. Slide 14: Industry Overview: China Medical Device Market and Opportunities

    Industry Overview 0 14 Source: Southern Institute of Medical Economics, 2023 Report on the Development of China’s Medical Device Industry. See offering documents for risks and further disclosures. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiq

  15. Slide 15: Deep Understanding of the Industry

    Deep Understanding of the Industry • 29 registered patents, 17 products registered with FDA, 3 products with CE Certification (1) • 7 out of 29 registered patents are for Inventions , 14 pending patent applications (1) Note: (1) As of the date of this presentation. 15 See offering documents for risk

  16. Slide 16: Cost-effective Masks, and Customized and Multifunctional Masks

    Cost - effective Masks, and Customized and Multifunctional Masks • The PRC subsidiaries upgraded their production equipment. They are able to manufacture more cost - effective products • After transforming the production lines into fully automated ones, and putting automatic headband mask machines i

  17. Slide 17: Diverse Product Portfolio

    Diverse Product Portfolio • Other than various masks, we provide 16 kinds of medical consumable products, which are widely used in the anesthesiology department during surgery. Artery Compression Tourniquets Disposable Breathing Circuits Laryngeal Mask Airways Endotracheal Tubes Endotracheal Tube Ho

  18. Slide 18: Wide Distribution Network

    Wide Distribution Network • Exporting distributors span across 6 continents • Sold the products in 30+ countries 7.20% 7.13% 92.80% 92.87% Oversea Domestic Revenue Disaggregates by Geographic Market FY2022 (2) FY2023 (2) • Reach approximately 48 global customers (1) Our Global Presence 18 Note: (1)

  19. Slide 19: Experienced Management Team

    Experienced Management Team Shuang Wu Chief Executive Officer, Director Chairman of the Board of Directors • Mr. Wu has extensive managerial and financial experience. • Chief Operating Officer of EZGO Technologies Ltd (Nasdaq: EZGO) from August 2019 to May 2022. • Vice president of Changzhou Hengmao

  20. Slide 20: Independent Directors

    Independent Directors Xiaoyang Li Independent Director Appointee • Mr. Li’s law practices cover multiple including IPO, merger and acquisition, fields, private equity, foreign direct investment, and commercial arbitration. • Senior partner of DeHeng Law Office (Shenzhen) since March 2008 . • Attorne

  21. Slide 21: Growth Strategies

    Growth Strategies Continue to invest in the PRC subsidiaries’ R&D team • We plan to deepen the PRC subsidiaries’ collaboration with medical institutions and invest additional capital in R&D on technology and new product to add new items to the product portfolio Expand the PRC subsidiaries’ sales and

  22. Slide 22: Financial Highlights

    Financial Highlights Revenue US$ Million 19.71 13.57 9.01 5.31 FY2022 FY2023 1H2023 Unaudited1H2024 Unaudited 22.41% 22 Note: Fiscal year ended September 30. For the six months ended March 31. See offering documents for risks and further disclosures. There is no guarantee that any specific outcome w

  23. Slide 23: Financial Highlights: Revenue Breakdown

    Financial Highlights Revenue Breakdown by Segments Mask Medical device other than mask Commodity trading Others 53.87% 44.38% 0.54% 1.21% FY2022 FY2023 37.53% 58.95% 2.40% 1.12% 52.74% 43.73% 2.86% 0.67% 1H2023 Unaudited 1H2024 Unaudited 10.67% 85.97% 3.35% Revenue Breakdown by Geographic Market Ove

  24. Slide 24: Contacts

    Contacts Issuer: WORK Medical Technology Group LTD Underwriter: Kingswood Capital Partners, LLC Email: ir@workmedtech.com Tel: +86 - 0571 - 82613568 Address: Building 23, No. 2 Tonghuinan Rd., Xiaoshan District, Hangzhou, China, 311200 Email: lciervo@kingswoodus.com Tel: +1 - 800 - 535 - 6981 Addres

WORK Medical Technology Group — IPO Roadshow (August 2024) on 6ix